Welcome to our dedicated page for Pro-Dex Colo SEC filings (Ticker: PDEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the story behind Pro-Dex’s precision surgical drivers and motion-control boards? Most investors start by scanning a single Form 8-K, then realise the real details hide across hundreds of pages of 10-K, 10-Q and proxy statements. This page brings every Pro-Dex SEC filing into one place and, more importantly, explains what each document means for revenue tied to a handful of medical-device OEMs, FDA compliance costs, and new driver technology in development.
Use Stock Titan’s AI summaries to turn the dense language of a Pro-Dex annual report 10-K simplified into clear bullet points, or let our engine flag sudden shifts in backlog within the latest Pro-Dex quarterly earnings report 10-Q filing. Need immediate alerts? We stream Pro-Dex Form 4 insider transactions real-time so you can track director purchases the moment they hit EDGAR. Curious about pay packages? The Pro-Dex proxy statement executive compensation section is distilled so you can compare cash bonuses to patent milestones in seconds.
Common tasks become effortless: monitor Pro-Dex insider trading Form 4 transactions before material announcements, dissect segment margins with our Pro-Dex earnings report filing analysis, and see every Pro-Dex 8-K material events explained without opening a single PDF. Whether you’re underwriting credit, valuing the stock, or simply understanding Pro-Dex SEC documents with AI, this hub delivers all filings, real-time updates, and plain-English insights—so you spend time on decisions, not document mining.
PRO DEX INC (PDEX)11/21/2025. The filing shows the director acquired 900 shares of common stock at a price of $32.73 per share in a directly owned account, bringing the directly held total to 2,900 shares. On the same date, an additional 2,200 shares of common stock were acquired at $32.70 per share and are reported as indirectly owned by the director’s spouse, bringing the spouse’s reported indirect holdings to 16,896 shares. The filing is signed by an attorney-in-fact on behalf of the reporting person.
PRO DEX INC (PDEX)
The filing explains that these 72 shares were forfeited to pay payroll taxes related to the vesting of 200 restricted shares that were originally granted on 11/20/2024 under the company’s 2016 Equity Incentive Plan. This is a routine tax-withholding event tied to equity compensation rather than an open-market sale.
Pro-Dex, Inc. (PDEX) insider equity grant: Director and 10% owner Nicholas John Swenson received a grant of 1,000 shares of Pro-Dex common stock on 11/20/2025 at a stated price of $0.00 per share. These are restricted shares issued under the company’s 2016 Equity Incentive Plan and vest in equal installments over five years, conditioned on his continued service to Pro-Dex during the vesting period.
After this grant, he beneficially owns 97,613 shares directly and 926,730 shares indirectly through AO Partners I, LP. The filing is made as a Form 4 for a single reporting person.
Pro-Dex, Inc. (PDEX) director Katrina Marie Kramer Philp reported an equity grant from the company. On 11/20/2025 she received 1,000 shares of common stock as an award of restricted shares under Pro-Dex’s 2016 Equity Incentive Plan at a stated price of $0.00 per share. After this grant, she beneficially owns 2,000 common shares directly and 14,696 common shares indirectly through her spouse.
The restricted shares vest in equal installments over five years following the grant date, and vesting depends on her continued service to Pro-Dex during that period. The filing is made as a Form 4 for a single reporting person in her capacity as a director of the company.
Pro-Dex, Inc. (PDEX) director David C. Hovda reported receiving a grant of 1,000 shares of Pro-Dex common stock on 11/20/2025. The filing shows these shares were acquired at a stated price of $0, reflecting a restricted stock award rather than an open‑market purchase. Following this grant, Hovda beneficially owns 4,300 Pro-Dex shares in direct ownership.
The 1,000 restricted shares were granted under Pro-Dex’s 2016 Equity Incentive Plan. They vest in equal installments over five years after the grant date, as long as Hovda continues to provide service to Pro-Dex during the vesting period. This Form 4 simply records the equity compensation awarded to a board member and the resulting change in his share ownership.
Pro-Dex, Inc. (PDEX) director received a grant of 1,000 shares of common stock on 11/20/2025. The shares were granted at a price of $0.00 under the company’s 2016 Equity Incentive Plan as restricted stock.
These restricted shares vest in equal installments over the five years following the grant date, and vesting depends on the director’s continued service to Pro-Dex during this period. After this grant, the reporting person beneficially owns 2,000 shares directly and 5,100 shares indirectly through an IRA.
Pro-Dex, Inc. (PDEX) director equity activity shows a small tax-related share forfeiture and a new restricted stock grant. On 11/20/2025, the reporting director forfeited 72 shares of common stock at a price of $30.83 to cover payroll taxes tied to the vesting of 200 restricted shares that were granted on 11/20/2024 under Pro-Dex's 2016 Equity Incentive Plan. On the same date, the director received a grant of 1,000 restricted common shares for no cash payment, also under the 2016 Equity Incentive Plan. These restricted shares vest in equal installments over five years, contingent on continued service with Pro-Dex. After these transactions, the director beneficially owned 15,447 common shares, held directly.
Pro-Dex, Inc. (PDEX) filed a Form 4 showing equity-related transactions by its Chief Financial Officer, Alisha Charlton. On 11/20/2025, 72 shares of common stock were forfeited at a price of $30.83 per share to cover payroll taxes tied to the vesting of 200 restricted shares granted on 11/20/2024 under the company’s 2016 Equity Incentive Plan. On the same date, Charlton received a grant of 1,000 restricted shares at a price of $0, also under the 2016 Equity Incentive Plan. Following these transactions, she beneficially owned 17,267 shares of Pro-Dex common stock directly. The newly granted restricted shares vest in equal installments over five years, as long as she continues her service with Pro-Dex over the vesting period.
Pro-Dex, Inc. (PDEX)1,000 shares of common stock at a price of $0.00, described as a grant of restricted shares under the company’s 2016 Equity Incentive Plan.
Following this grant, he beneficially owns 2,000 common shares directly and 270,846 common shares indirectly through Farnam Street Partners, L.P. This filing is a standard Form 4 disclosure of insider ownership and compensation in stock.
Pro-Dex, Inc. reported compensation actions and shareholder voting results. The Compensation Committee granted restricted common shares under its 2016 Equity Incentive Plan to non-employee directors and select employees, including 1,000 restricted shares to CFO Alisha K. Charlton, vesting in equal installments over five years, generally contingent on continued employment.
The Committee also approved a discretionary cash bonus to CEO Richard L. Van Kirk of $30,830, equal to the value of 1,000 shares based on the Nasdaq Capital Market closing price on November 20, 2025, to be paid in the next bi-weekly pay period. At the 2025 Annual Meeting, all director nominees were elected, shareholders ratified the company’s independent registered public accounting firm, approved on an advisory basis the compensation of Named Executive Officers and chose an annual advisory vote on that pay, and approved an additional proposal.
FAQ
What is the current stock price of Pro-Dex Colo (PDEX)?
What is the market cap of Pro-Dex Colo (PDEX)?
